News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MANNINO RAPHAEL J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2018 |
4
| MANNINO RAPHAEL J (Chief Scientific Officer) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Bought 10 convertible preferred
@ $0.5, valued at
$5 |
|
| 05/02/2018 |
4
| MANNINO RAPHAEL J (Chief Scientific Officer) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.44, valued at
$66k
|
|
| 09/15/2017 |
4
| MANNINO RAPHAEL J (Chief Scientific Officer) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Bought 5,000 shares
@ $1.41, valued at
$7.1k
|
|
| 08/23/2013 |
4
| MANNINO RAPHAEL J (Director) has filed a Form 4 on BIOVEST INTERNATIONAL INC|
Txns:
| Disposed of 176,750 options to buy
@ $0.57, valued at
$100.7k
Disposed of 102,500 options to buy
@ $0.07, valued at
$7.2k
Disposed of 200,000 options to buy
@ $0.69, valued at
$138k
Disposed of 60,000 options to buy
@ $0.5, valued at
$30k
Disposed of 75,000 options to buy
@ $1.13, valued at
$84.8k
Disposed of 75,000 options to buy
@ $0.66, valued at
$49.5k
|
|
| 04/03/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/20/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|